Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancerYunong Xie(Chinese University of Hong Kong), Man Tong(Chinese University of Hong Kong)Cell Death and DiseaseFebruary 3, 202410.1038/s41419-024-06493-0Cited by 18SaveCiteExport RISWatch citationsRelated PapersCaspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma|Cancer Research|2022|106Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma|Unknown|2023|0Supplementary Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma|Unknown|2023|0Supplementary Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma|Unknown|2023|0Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma|Unknown|2023|0